Issued Patents 2017
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9789165 | Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists | Katrin Lorenz, Andreas Evers, Torsten Haack, Michael Wagner, Bernd Henkel +2 more | 2017-10-17 |
| 9782411 | {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury | Véronique Briand, Sabine Gratzer, Thomas Huebschle, Philip Janiak, Ashfaq Parkar +3 more | 2017-10-10 |
| 9758520 | Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | Lothar Schwink, Christian Buning, Heiner Glombik, Matthias Gossel, Nis Halland +3 more | 2017-09-12 |
| 9758561 | Dual GLP-1/glucagon receptor agonists derived from exendin-4 | Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin +1 more | 2017-09-12 |
| 9750788 | Non-acylated exendin-4 peptide analogues | Katrin Lorenz, Andreas Evers, Torsten Haack, Michael Wagner, Bernd Henkel +2 more | 2017-09-05 |
| 9751926 | Dual GLP-1/GIP receptor agonists | Katrin Lorenz, Andreas Evers, Torsten Haack, Michael Wagner, Bernd Henkel +2 more | 2017-09-05 |
| 9694053 | Dual GLP-1/glucagon receptor agonists | Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers +1 more | 2017-07-04 |